Latest Safety News

OncoSil Medical has clinched TGA approval for its OncoSil™ device, the first Class III medical device targeting pancreatic tumours in Australia, paving the way for local commercialisation and enhanced patient access.

Dalrymple Bay Infrastructure Limited (DBI) forecasts an 8.1% increase in terminal infrastructure charges for TY-26/27, alongside an 8.5% uplift in distribution guidance, reflecting strong operational performance and ongoing capital investment.

ClearVue Technologies has secured TÜV SÜD certification for its Thermal Management Junction Box, validating its safety and durability for global BIPV deployment.

Amplia Therapeutics has launched a Phase 2b trial testing a new daily dosing regimen of narmafotinib combined with chemotherapy in advanced pancreatic cancer, aiming to accelerate progress towards a pivotal Phase 3 study.

TMK Energy has inked a MoU with Dashvaanjil Group to develop a 1MW gas-to-power plant at its Gurvantes XXXV project, aiming to secure reliable onsite power and open commercial gas sales by Q3 2026.

New Hope Corporation lifted quarterly coal production and sales, cut sustaining capital guidance, and issued $300 million in convertible notes to extend debt maturity to 2032.

Classic Minerals has restated its 80% beneficial interest in the Forrestania Gold Project, emphasizing that recent acquisitions by Forrestania Resources do not affect its rights, which remain protected amid ongoing Supreme Court litigation.

OncoSil Medical’s interim OSPREY Registry data show strong safety and promising survival outcomes for its targeted radiotherapy device in unresectable locally advanced pancreatic cancer, surpassing historical benchmarks.

Novo Resources narrowed its Q1 2026 net loss to CAD 685K, boosted cash to CAD 10.6M following a $5.9M placement, and outlined aggressive gold and antimony drilling campaigns in Australia.

Neurizon Therapeutics has gained ethics approval to start a Phase 1 trial of its NUZ-001 oral liquid formulation, aiming to ease treatment for ALS patients with swallowing difficulties.

Nexsen has secured a strategic partnership with GHK Hospital Limited in Hong Kong, marking a significant step in validating and commercialising its rapid point-of-care diagnostics across North Asia.

Li-S Energy has secured vital approvals to airfreight lithium-sulfur prototype cells to the United States, paving the way for direct engagement with US defence and drone sectors.